The company said, “The company expects sales growth from continuing operations of 4% to 5% on a reported basis and 1% to 2% on an operational basis. The company expects adjusted earnings from continuing operations, before special items, of $0.59 to $0.63 per diluted share.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BAX:
- Baxter call volume above normal and directionally bullish
- Is BAX a Buy, Before Earnings?
- Baxter participates in a conference call with JPMorgan
- Baxter International: Navigating Leadership Transition and Market Growth Amidst Tariff Challenges
- Baxter International Appoints New Leadership Amid Strategic Changes